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Summary, general discussion and conclusions
Chapter Ten
General discussion
In this thesis the feasibility of multiparameter flow cytometric analyses in routinely processed
formalin fixed, paraffin embedded tissues has been examined. Next to this, several clinical
applications of this approach have been investigated.
Feasibility and modifications to the technique
In chapter 2 it was shown that it is possible to perform multiparameter DNA flow cytometry
on formalin fixed, paraffin embedded tissues. After preparing a single-cell suspension the cells
had retained enough cytoskeletal remnants to allow immunocytochemical detection of the
cytokeratins. Labeling of the cytokeratins can be used to restrict the flow cytometric analysis
to the epithelial compartment of a tumor after selection of the cytokeratin-positive cells. As
shown in chapter 2, but also by several other investigators *"*"', exclusion of nonepithelial
cells (inflammatory cells and stromal compartment) from the flow cytometric analysis
increases the accuracy of the SPF calculation and could enhance the prognostic value of DNA
flow cytometry. In diploid tumors this multiparameter flow cytometric analysis allows a more
objective SPF calculation due to this exclusion of normal non-epithelial cells. Also, the quality
of the DNA histogram improved as indicated by a decrease in CV.
There are several enzymes which can be used to prepare the single cell suspension. Pepsin has
a broad range of nonspecific proteolytic activities. After pepsin digestion, this Ki67-epitope
was not detectable anymore with the Ki67-antibodies tested. On the other hand, trypsin is a
more specific enzyme: a serine protease that hydrolyses peptide bonds involving carboxyl
groups of arginine and lysine. This specificity of trypsin can be used to detect a Ki67-epitope
using a particular Ki67-antibody (KiS5) in cell suspensions prepared from formalin fixed,
paraffin embedded breast tumors (chapter 3).
A drawback of enzymatic digestion is that due to the long digestion period (more than one
hour) many epitopes are destroyed, especially the membrane bound antigens. When the 50 |im
thick deparaffinized and rehydrated sections were heated for 2 hours at 80°C in a citrate
solution, a very short pepsin digestion of maximally 15 minutes was sufficient to release more
than enough cells from the section to perform a multiparameter flow cytometric analysis
(chapter 4). Due to the very short enzymatic digestion, many epitopes survive the adverse
effects of an enzymatic treatment. Next to this, the heating step in citrate solution has also an
antigen retrieving effect. Now it is possible to detect epitopes which could not be analysed
before in paraffin embedded tissues, for example the steroid receptors (chapter 7),but even
cell membrane bound epitopes such as E-Cadherin (unpublished observations) and CD-
markers on lymphoid cells (chapter 8).
Another advantage of this technique is that the adverse effects of formalin fixation on the
nuclear dye uptake are counteracted. This leads to an improvement of the quality of the DNA
histogram (low CV, small fraction of background and debris). Formalin fixation leads to the
formation of methylene bridges between amino-acids in the DNA and/or proteins. Heating in
an acidic environment (the citrate solution has a pH of 6.0) leads to an extraction of chromatin
proteins which results in more binding sites for propidium. It was also shown in chapter 4
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that the duration of fixation with formalin up to 72 hours has no influence on propidium iodide
uptake. When using external reference cells this new method can facilitate the standardisation
of flow cytometry on formalin fixed, paraffin embedded tissues. The presented method allows
for the setup of standardization and quality controls.
Using an indirect immunostaining method, it is possible to perform a three-parameter flow
cytometric analysis of formalin fixed, paraffin embedded tissues (chapter 3, 5, 6, 7, 8 and 9).
Next to a DNA-staining with propidium iodide, it is possible to label simultaneously two
epitopes using a combination of a mono- and a polyclonal antibody. However, it is even
possible to use a combination of two monoclonal antibodies when using immunoglobulin-
isotype different monoclonal antibodies (e.g. an IgG,- and an IgG2a or IgG2t,-monoclonal
antibody; chapter 6).
Clinical applications
A significant limitation of using a single marker to predict disease course (i.e. DNA ploidy or
SPF) is that it fails in a number of individual patients. One reason is the presence of tumor
heterogeneity. Other reasons include technical issues, which limit the reproducibility of the
assay. A consensus panel suggested that multiparameter techniques would improve the
accuracy and prognostic utility of flow cytometric data "". Much of the clinical applications
of flow cytometry have thus far centered around the use of cell surface phenotyping in the
analysis of fresh material of leukemias and lymphomas. Although DNA ploidy and S-phase
analysis have been performed in clinical laboratories for over twenty years, they have limited
impact on clinical management of solid tumors at the present time. An important factor that
has contributed to this was the lack of reproducibility of many studies, especially those
performed on formalin fixed, paraffin embedded tissues. It was shown in this thesis that this
problem can be solved by the new heating/short digestion method to prepare single cell
suspensions from the paraffin embedded tissues (chapter 4). Due to this new method a higher
DNA histogram resolution was achieved resulting in a better recognition of peridiploid tumor
cell populations. Using multiparameter flow cytometry direct correlations could be made
between the expression of a tumor marker in a certain cell population on the one hand, and
ploidy level and SPF on the other hand. In chapter 7 it was shown in patients with a breast
tumor that this analysis leads to the identification of four subsets of patients:
1. patients with DNA aneuploid tumors, high SPF and low ER-expression
2. patients with DNA aneuploid tumors, including the peri- and tetraploid ones, intermediate
SPF and relatively high ER-expression
3. patients with DNA diploid tumors, low SPF, high ER- and high PR-expression, and finally
4. patients with DNA diploid tumors, low SPF, high ER- and low PR-expression
From several studies it is known that patients suffering from tumors with a diploid DNA
profile, low SPF and high ER-expression respond better to hormonal treatment. On the other
hand, it was also shown that patients with aneuploid tumors or tumors with a high SPF have a
significantly increased rate of tumor relapse ^ An advantage of the method described in
chapter 7 is that these different parameters (steroid hormone receptor expression, DNA
ploidy and SPF) are obtained within one single assay and are all related to the same
investigated cell population. Next to the steroid hormone receptors, cell membrane bound
epitopes could be analysed. In the same group of breast tumors investigated in chapter 7, the
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expression of the cell membrane bound epitope E-cadherin was investigated (unpublished
observations). It was shown that this expression was correlated to the N-stage of the tumor,
i.e. tumors, which had not metastasized, had a high E-cadherin expression. Most of these
tumors were also diploid. Tumors which had metastasized showed next to aneuploidy no or
decreased expression of E-cadherin.
Barnard et al have found in breast tumors that the expression of the proliferation-associated
antigen Ki67 provides an objective indicator of biological behaviour and may thus be of
clinical significance. In chapter 3, a rapid, objective multiparameter flow cytometric method
is described to analyse the expression of the Ki67-epitope in cell suspensions from formalin
fixed, paraffin embedded breast tumors.
The expression of the above-described proteins (steroid hormone receptors, E-cadherin and
Ki67) was always investigated in the relevant epithelial compartment of the tumor: the
cytokeratin-positive cell population. For this purpose, a polyclonal pan-cytokeratin antibody
was used to label these cells. However the different lineages of epithelial differentiation and
their tumors are characterised by the expression of a certain subset of cytokeratins. In chapter
6 it was shown that a differentiation could be made between normal bronchial epithelium and
tumor epithelium in one single flow cytometric analysis of lung carcinomas when using
monoclonal antibodies directed to certain cytokeratin subtypes. Now it is possible to study the
expression of a certain protein during differentiation ofthat cell.
From several studies it is known that cytokeratin filaments aggregate at an early stage of the
apoptotic process *"'"\ This aggregation is accompanied by caspase cleavage of the cytokeratin
filaments *. In chapter 5 we characterised antibody M30, which can be used in a routine
setting for the analysis of the apoptotic process by multiparameter flow cytometry. Early in
the apoptotic cascade, caspase-cleavage of cytokeratin 18 takes place. A neo-epitope is then
generated which is recognized by the monoclonal antibody M30. In this chapter it is excluded
that this epitope is present in vital and necrotic cells. It was also shown that this epitope is not
generated by hyperphosphorylation (artificial or natural during mitosis) of cytokeratin 18.
Because cytokeratin 18 has a widespread distribution in practically all simple, non-stratified,
ductal and pseudostratified epithelia, it can be used for studies of many types of carcinomas.
Furthermore, recent studies in cell lines have shown that the caspase cleaved CK.18 fragments,
which are detectable by M30, are finally shed into the culture medium (Kölgen et al,
manuscript in preparation). Measuring serum levels of these fragments could provide a simple
assay to monitor progression of disease or response to therapy.
In chapter 9 proliferation (SPF) and apoptosis (bcl-2, M30) was studied in benign and
malignant disorders of the endometrium. Multiparameter flow cytometric evaluation of these
three parameters could help to assist in the identification of patients at risk for endometrial
cancer: patients with a low number of M30 positive cells combined with a high number of bcl-
2 positive cells in hyperplastic endometrium. With this method it was also possible to make a
differential diagnosis between hyperplastic from non-hyperplastic endometrial lessions.
In chapter 8 it was shown that next to cytokeratin also cell surface epitopes can be used to
characterize certain subpopulations of cells. The cell surface markers CD79a and CD3 were
used to label the B- and T-lymphocyte population within paraffin embedded lymphatic tissue.
Furthermore, the expression of immunoglobulin light chains was investigated within the
CD79a-positive population. Using this method it was possible to detect clonal expression of
one of the two immunoglobulin light chains in 9 out ot 10 non-Hodgkin's lymphomas. In this
way a differentiation could be made between the expression of the light chain
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immunoglobulins in the normal diploid lymphocytes (both K- and X-light chain expression)
and that of the peridiploid tumor cells (no light chain expression). With routine
immunohistochemical techniques it was only possible to detect clonal expression in 6 out of
ten cases.
Future research , ,.
To test the clinical value and the prognostic significance of the above mentioned applications,
it is of importance to repeat these studies in a series of tumors with a long follow up of a well
documented cohort of patients to get a definitive answer. Because the flow cytometric
technique now works excellent on routinely processed formalin fixed, paraffin embedded
material, such series can now be selected. Now that it is shown that the technique of
multiparameter flow cytometry works on formalin fixed, paraffin embedded tumors it is of
importance to look for the right combinations of markers, that provide information about the
biological behavior of the tumor. An example is the analysis of the expression of apoptosis-
inhibiting proteins. At the moment, several trials have been initiated in which apoptotic
pathways are manipulated. In prostate cancer for example, it has been shown that
downregulation of bcl-2 expression with gene-specific antisense oligonucleotide probes
abolish the bcl-2 conferred resistance to apoptosis induction ' . These observations suggest
that bcl-2 can be a prime target for interference in preventing the generation of androgen-
refractory prostatic cancer cells. Blocking bcl-2 expression with unmodified or
phosphorothiate antisense oligonucleotides may also provide beneficial effects for combined
hormonal ablation and cytotoxic chemotherapy "*'".
In a pilot study we found that when calculating the ratio between apoptosis (as determined by
M30 expression) and proliferation (as determined by the SPF) a highly significant difference
exists between metastasised (Nl) and not metastasised breast tumors (NO). The NO-tumors
contained a higher ratio in contrast to the Nl-tumors (manuscript in preparation). Sheridan et
al found a similar result when calculating this ratio using morphological criteria (combination
of mitosis-counting and TUNEL-assay)'^. They found that cervical adenocarcinomas with a
high ratio had an improved survival after radiotherapy. This ratio, which we defined as the
Tumor Dynamic Index (TDI), is easily analyzed in a single-tube assay. In a pilot study on the
effect of photodynamic treatment of breast tumor explants in mice, a response was
accompanied with an increased TDI within several hours after treatment (personal
communication H. Walt). Multiparameter flow cytometry of fine needle aspirates of the
residual tumor, or malignant effusions, might be well suited to monitor cancer patients during
and after therapy.
Data analysis in multiparameter FCM is one of the limiting factors. Complex data files
containing more than three-parameters can require over 20 plots to visualize data trends across
all dimensions. It becomes difficult to find subpopulations with a certain marker profile when
the analysis is restricted to the two-dimensional plots generated by the most used analysis
programs. In order to visualize multiparameter flow cytometric data it is desirable to reduce
the dimensionality of these data to two while preserving important features of each data
pattern. Programs, which make use of attractors, have been developed recently. These are
cluster-seeking objects that automatically track user-defined cell populations. These attractors
are not static gates or quadrants, but are made up of dynamic gates. On subsequent analyses of
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samples, this software program automatically adjusts to relative changes in populations,
without the intervention of the operator. Next to this, the productivity, the quality and the
reproducibility of the flow cytometric analyses will improve when data analysis can be
automated.
However, the objectivity of the result of such quantification depends on the subjective
determination of thresholds and cut-off values when interpreting the flow cytometric
generated data by the investigator. This problem can be solved by adding reference cells to the
single cell suspensions. There is a variety of reference cells which can be used: cells with a
certain DNA content, with a certain diameter, labeled with a certain amount of fluorescent
probe etc. Using the method described in this thesis, the heating/ short digestion method, in
combination with those reference cells could lead to standardization of flow cytometry on
formalin fixed, paraffin embedded tissue. It also improves the possibility of exchanging
materials and results between diagnostic laboratories.
Conclusion
From the results of the various studies described in this thesis it can be concluded that
multiparameter flow cytometry of formalin fixed, paraffin embedded tissue is to become an
important tool for the surgical pathologist. It has many potential clinical applications and can
already now aid in the diagnosis of certain pathological disorders. It can give a more objective
quantification of the expression of several proteins as compared to the immunohistochemical
approaches or single-parameter flow cytometric analysis.
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In dit proefschrift worden de mogelijkheden van de multiparameter flow cytometrie in
routinematig verwerkt weefsel materiaal beschreven en worden klinische toepassingen
daarvan geillusteerd.
* r£CtfA7SC7/£A/OD/f7C477£S • - '
Na een algemene inleiding (hoofdstuk 1) wordt in hoofdstuk 2 aangetoond dat het mogelijk is
om multiparameter flow cytometrie te verrichten op formaline gefixeerd en in paraffine
ingebed materiaal. Na de bereiding van een celsuspensie door middel van een enzymatische
(pepsine) digestie-stap, blijkt dat de cellen genoeg cytoskelet-resten bezitten om daarin door
middel van immunochemische technieken epitopen aan te tonen, waaronder de cytokeratines.
Door het labelen van de cytokeratines kan door selectie de flow cytometrische analyse beperkt
worden tot het epitheliale compartiment van de tumor.
In hoofdstuk 3 wordt aangetoond dat door gebruik te maken van een modificatie in de
celsuspensie-bereidingsmethode (gebruik van trypsine in plaats van pepsine), het gevoelige
epitoop Ki67 (een proliferatie-geassocieerd eiwit) flow cytometrisch aangetoond kan worden.
Na een pepsine-digestie is het epitoop niet meer aantoonbaar. Wei moet benadrukt worden dat
alleen het Ki-S5 monoclonaal in staat is dit epitoop te labelen in celsuspensies van formaline
gefixeerd, paraffine ingebed weefsels. Een algemeen nadeel van de enzymatische digestie-
methode is dat zeer gevoelige epitopen, zoals die van celmembraan geassocieerde eiwitten, als
eerste vernietigd worden en dus niet meer aantoonbaar zijn middels immunochemie. In
hoofdstuk 4 van dit proefschrift onderzochten we daarom een methode waarbij
gedeparaffineerde en gerehydreerde dikke coupes (50 jam) 2 uur verhit worden in een citraat-
oplossing (pH 6.0) bij 80°C. Na een korte afkoelingsperiode blijkt een zeer korte enzymatische
digestie (5-10 minuten bij 30°C) voldoende om genoeg cellen te isoleren voor multiparameter
flow cytometrisch onderzoek. Een van de voordelen van deze methode is dat door de korte
digestie-stap veel epitopen behouden blijven waaronder de celmembraan geassocieerde
epitopen. Verder heeft de verhirting in de citraatoplossing een "antigen retrievar-effect. Het is
nu mogelijk om epitopen te herkennen die voorheen niet aantoonbaar waren in celsuspensies
bereid van formaline gefixeerde weefsels zoals bijvoorbeeld de steroid hormoonreceptoren
(hoofdstuk 7), E-cadherine (niet gepubliceerde data) en CD-markers op lymfoide cellen
(hoofdstuk 8). Een ander voordeel van deze techniek is dat het nadelige effect van formaline
fixatie op de binding van propidium iodide aan het DNA wordt opgeheven. Dit leidt tot een
verbetering van de kwaliteit van het DNA-histogram (läge CV, geringe fractie debris). Ook
blijkt de duur van de fixatie (tot 72 uur) geen rol meer te spelen op de bepaling van de ploidie.
Door referentiecellen mee te nemen kan deze nieuwe methode leiden tot standaardisatie van
flow cytometrie op formaline gefixeerde en in paraffine ingebedde weefselmateriaal. Deze
resultaten bieden nieuwe perspectieven voor de uitwisseling van kwaliteitscontrole-materiaal




Door het gebruik van multiparameter flow cytometrie is het mogelijk om de expressie van
bepaalde tumormarkers in specifieke celpopulaties direct te correleren aan ploidie-graad en S-
fase fractie. In hoofdstuk 3 wordt een (semi)kwantitatieve multiparameter flow cytometrische
techniek voor de expressie van het Ki67-epitoop in het epitheliale compartiment van formaline
gefixeerde, paraffine ingebedde mammarumoren beschreven. Uit de literatuur is bekend dat de
expressie van dit proliferatie-geassocieerd epitoop gerelateerd is aan het klinisch gedrag van
mammatumoren en dus van klinische betekenis kan zijn.
De expressie van de steroidhormoonreceptoren en Ki67 werd in deze gehele Studie steeds
onderzocht in het relevante epitheliale compartiment van de tumor: de cytokeratine positieve
celpopulatie. Voor dit doel werden de cellen gelabeld met een antilichaam gericht tegen een
algemeen voorkomend epitoop op het cytokeratine-filament (pan-cytokeratine antilichaam).
Echter, de verschillende vormen van epitheeldifferentiatie en de hieruit ontstane rumoren
worden gekenmerkt door een expressiepatroon van bepaalde cytokeratines. In hoofdstuk 6
wordt aangetoond dat door gebruik van antilichamen gericht tegen specifieke subtypes van
cytokeratines flow cytometrisch onderscheid kan worden gemaakt tussen normaal bronchiaal
epitheel en tumor epitheel in longtumoren. Het is dus mogelijk om op basis van deze
expressiepatronen longtumoren beter te typeren.
Vanuit verschillende studies is bekend dat de cytokeratine filamenten in een vroeg stadium
van het apoptose proces gaan aggregeren. Deze aggregatie word vergezeld door een klieving
van het cytokeratine filament door caspase. In hoofdstuk 5 wordt een antilichaam
gekarakteriseerd dat gericht is tegen een neo-epitoop op cytokeratine 18. Dit epitoop wordt
gegenereerd door een caspase-klieving van het cytokeratine 18, vroeg in het apoptose-proces
en wordt herkend door het M30-antilichaam. In dit hoofdstuk wordt aangetoond dat het
epitoop niet aanwezig is in vitale of necrotische cellen en niet gegenereerd wordt door
hyperfosforylatie van cytokeratine 18. Daar cytokeratine 18 wijdverbreid voorkomt in
praktisch alle nietverhoomende epithelia, kan het antilichaam gebruikt worden in studies van
veel typen epitheliale rumoren.
In hoofdstuk 7 wordt de expressie van steroidhormoonreceptoren gecorreleerd aan
ploidiegraad en S-fase fractie in een groep patienten met een mammacarcinoom. Door de
expressie van de steroidhormoonreceptoren (ER en PR) in de epitheliale fractie van de tumor
te correleren aan ploidie en S-fase fractie, kunnen een aantal subgroepen van patienten
onderscheiden worden. Uit de literatuur is bekend dat patienten die een tumor hebben met een
diploid DNA-profiel, läge proliferatieve acriviteit en hoge steroid hormoonreceptor expressie
beter reageren op hormonale therapie. Anderzijds is ook aangetoond dat patienten met een
aneuploide mammatumor, een läge expressie van steroidhormoonreceptoren of een tumor met
een hoge S-fase fractie een significante toename vertonen van terugval in de ziekte.
In hoofdstuk 9 worden de proliferatieve, bcl-2 expressie (apoptose-remming) en apoptotische
activiteit (M30) onderzocht in benigne en maligne afwijkingen van het endometrium.
Multiparameter flow cytometrische evaluatie van deze drie parameters kan een steun zijn bij
het vaststellen van een subgroep van patienten met hogere risico's voor het ontwikkelen van
een endometriumcarcinoom, namelijk een groep endometriumafwijkingen met een geringe
fractie van M30-positieve cellen gecombineerd met een hoge bcl-2 expressie in hyperplastisch
endometrium. Met deze methode is het ook mogelijk om een differentiaal diagnose te maken
tussen hyperplastische en niet-hyperplastische endometriumafwijkingen.
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Naast de cytokeratines kunnen ook membraan-eiwitten gebruikt worden om bepaalde
subpopulaties van cellen te karakteriseren. In hoofdsruk 8 wordt aangetoond dat
celmembraangebonden epitopen bij uitstek geschikt zijn om de verschallende populaties in
lymfatisch weefsel te labelen. Door gebruik te maken van antilichamen gericht tegen CD3 en
CD79a kunnen respectievelijk de T- en B-lymfocytenpopulaties aangetoond en
gekwantificeerd worden in celsuspensies bereid van paraffine ingebedde lymfoproliferatieve
afwijkingen. Daarnaast wordt getoond dat binnen de CD79a-positieve populatie de expressie
van de immunoglobuline lichte ketens onderzocht kan worden. Door gebruik te maken van
deze methode was het mogelijk om klonale expressie van een van de twee types
immunglobuline lichte ketens aan te tonen in 9 van 10 non-Hodgkin's lymfomen. Met de
routinematig toegepaste immunohistochemische techniek was dit in 6 van de 10 gevallen
mogelijk. Door gebruik te maken van de simultane DNA-aankleuring met propidium iodide
kon ook nog onderscheid gemaakt worden tussen de expressie van de immunoglobuline lichte
ketens in de diploide en aneuploide lymfocyten.
Aan de hand van de verschillende resultaten zoals beschreven in dit proefschrift kan
gekonkludeerd worden dat de multiparameter flow cytometrische techniek toegepast op
routinematig verwerkt formaline gefixeerd, paraffine ingebed materiaal een belangrijk
hulpmiddel in de diagnostiek van de klinisch patholoog kan zijn. Op gebied van de
kwantificering geeft de multiparameter flow cytometrie een objectiever resultaat in
vergelijking tot immunohistochemische benaderingen.
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